• রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন।
DIAMICRON MR 60 MG is used for the treatment of type 2 diabetes mellitus, particularly when diet and exercise alone do not provide sufficient blood glucose control. The active ingredient Gliclazide works by stimulating the pancreas to release insulin, thereby helping to lower blood sugar levels. The modified release (MR) formulation ensures that the drug is released gradually, providing a steady effect throughout the day and helping maintain blood glucose control.

Pharmacology:
DIAMICRON MR 60 MG contains Gliclazide, a sulfonylurea class drug that helps manage type 2 diabetes. Gliclazide works by stimulating the pancreatic beta cells to release insulin, a hormone that reduces blood glucose levels. It also enhances the body’s sensitivity to insulin, thereby improving glucose uptake by cells. The MR formulation ensures slow, consistent drug release, allowing for better control of blood sugar levels throughout the day and reducing the risk of hypoglycemia (low blood sugar).

Dosage:

• The usual starting dose for adults with type 2 diabetes is 30 mg to 60 mg once daily, taken with breakfast.

• The dosage may be adjusted by the doctor based on the patient's blood sugar levels and individual response to treatment.

• The maximum recommended dose is typically 120 mg per day, in divided doses.

• Always follow your doctor’s instructions for the correct dosage.

Administration:
Take DIAMICRON MR 60 MG once daily, with food, preferably during or after breakfast. Swallow the tablet whole with a glass of water. Do not crush, chew, or break the tablet, as this may affect the controlled-release properties. Consistent timing and regular intake are essential for effective blood glucose control.

Interaction:
DIAMICRON MR 60 MG may interact with other medications, including:

• Insulin or other antidiabetic drugs: The combination may increase the risk of hypoglycemia.

• Antifungals, antibiotics, or corticosteroids: These may affect blood sugar levels and interact with Gliclazide.

• Beta-blockers: These may mask symptoms of hypoglycemia and alter blood glucose control.

• Diuretics and other antihypertensive medications: These may alter the effectiveness of Gliclazide.
  Always inform your healthcare provider about all other medications or supplements you are taking.

Contraindications:
DIAMICRON MR 60 MG should not be used by individuals who:

• Are allergic to Gliclazide or any of the other ingredients in the medication.

• Have type 1 diabetes mellitus or diabetic ketoacidosis.

• Have severe liver or kidney disease.

• Are pregnant or breastfeeding.

• Have a history of severe allergic reactions to sulfonylurea drugs.

Side Effects:
Common side effects may include:

• Nausea, vomiting, or gastrointestinal discomfort.

• Headache, dizziness, or lightheadedness.

• Weight gain, especially with long-term use due to increased insulin levels.
  Serious side effects can include:

• Hypoglycemia (low blood sugar), which can cause symptoms like trembling, sweating, confusion, and dizziness. Severe hypoglycemia can lead to loss of consciousness.
  If you experience symptoms of hypoglycemia or other severe side effects, seek immediate medical assistance.

Pregnancy & Lactation:
Pregnancy:
DIAMICRON MR 60 MG should not be used during pregnancy, particularly in the first trimester. Insulin therapy is recommended during pregnancy to control blood glucose levels. Consult your doctor if you are pregnant or planning to become pregnant.
Lactation:
Gliclazide is excreted in breast milk and may affect the baby. It is generally not recommended for use during breastfeeding. Consult your healthcare provider before using this medication while breastfeeding.

Therapeutic Class:
Sulfonylureas (oral hypoglycemic agents).

Storage Conditions:
Store DIAMICRON MR 60 MG at room temperature, away from moisture, heat, and direct sunlight.
Keep the medication tightly closed in its original container.
Keep out of the reach of children.
Do not use the medication after the expiration date printed on the packaging.